We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: NA
Packaging Information: 25kg/drum
Delivery Lead Time: 10-30days
Sample Provided: yes
Payment Terms: TT; L/C;
Naphthoquine Phosphate Pharmaceutical grade CAS Number 173531-58-3 Molecular Formula C24H28ClN3O•2H3PO4•2 Molecular Weight 641.98 Package：25kg/drum Function: treat Plasmodium falciparum, malaria tertiana and drug resistant plasmodium Application: Anti malaria API Tags: Anti Bacterial Toxic Expelling.
Naphthoquine phosphate has killing effect on various plasmodium falciparum schizont and some plasmodium gametocyte and organisation of protozoa, it has good cure effect on drug-resistant plasmodium and long-term preventive effect on plasmodium.
Naphthoquine phosphate is suitable for treatment of Plasmodium falciparum, malaria tertiana and drug resistant plasmodium.
Quality standard：CP
Quality index：
Property：light yellow or yellow crystalline powder
Assay：> 98.5%(HPLC)
Application：Anti malaria API
Naphthoquine phosphate has killing effect on various plasmodium falciparum schizont and some plasmodium gametocyte and organisation of protozoa, it has good cure effect on drug-resistant plasmodium and long-term preventive effect on plasmodium.
Naphthoquine phosphate is suitable for treatment of Plasmodium falciparum, malaria tertiana and drug resistant plasmodium.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
